These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3286406)
1. [New inotropic agents in the treatment of refractory congestive heart failure]. Hertzeanu H; Pines A Harefuah; 1988 Mar; 114(6):290-3. PubMed ID: 3286406 [No Abstract] [Full Text] [Related]
2. New positive inotropic drugs in the treatment of congestive heart failure. Kennedy GT Prog Cardiovasc Nurs; 1987; 2(3):100-4. PubMed ID: 2959954 [No Abstract] [Full Text] [Related]
3. Milrinone, a new agent for the treatment of congestive heart failure. Hasegawa GR Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085 [TBL] [Abstract][Full Text] [Related]
4. New positive inotropic agents for congestive heart failure. N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614 [No Abstract] [Full Text] [Related]
5. [Rational and irrational approach to the inotropic agent therapy of heart failure]. Colombo F; Libretti A Clin Ter; 1988 Sep; 126(6):421-6. PubMed ID: 2974404 [No Abstract] [Full Text] [Related]
6. The role of novel inotropic agents in the treatment of heart failure. LeJemtel TH; Keren G; Reis D; Sonnenblick EH J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542 [TBL] [Abstract][Full Text] [Related]
7. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. Colucci WS; Wright RF; Braunwald E N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353 [No Abstract] [Full Text] [Related]
8. Milrinone: a positive inotropic vasodilator. Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335 [No Abstract] [Full Text] [Related]
9. New inotropic drugs: amrinone and milrinone. Lemke JV J Med Assoc Ga; 1987 Dec; 76(12):854-7. PubMed ID: 3694072 [No Abstract] [Full Text] [Related]
16. Oral milrinone in severe chronic heart failure. Feldman AM; Baughman KL; Strobeck JE N Engl J Med; 1992 Jun; 326(23):1565-6; author reply 1567. PubMed ID: 1579142 [No Abstract] [Full Text] [Related]
17. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure. Tommaso CL Am J Med; 1986 Feb; 80(2B):36-9. PubMed ID: 3004210 [No Abstract] [Full Text] [Related]
18. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
19. Myocardial and vascular effects of intracoronary versus intravenous milrinone. Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193 [No Abstract] [Full Text] [Related]
20. Oral milrinone in severe chronic heart failure. Desjardins S N Engl J Med; 1992 Jun; 326(23):1565; author reply 1567. PubMed ID: 1579141 [No Abstract] [Full Text] [Related] [Next] [New Search]